Cesare Gridelli, MD, is currently Chief of Division of Medical Oncology at the “S.G. Moscati” Hospital, Avellino (Italy). From December 2003 to February 2017, he was Director of the Department of Oncology/Haematology at the same institution.

Dr Gridelli earned his medical degree and residencies in Internal Medicine and later in Medical Oncology at the “Federico II” University of Naples (Italy). Since 1993 he has been Vice-Chief of Division of Medical Oncology B, National Cancer Institute of Naples and since 2001 Chief of the Day Hospital Chemotherapy Unit at the same Institute.

Dr Gridelli’s areas of expertise are lung cancer and cancer in the elderly. He is deeply involved in the clinical development of new anticancer targeted therapies and immunotherapy. He is President of the Italian Association of Thoracic Oncology (AIOT), member of several national and international scientific societies and member of the Advisory Board of scientific journals as well as of several expert panels. Dr Gridelli has been invited speaker at several international conferences and educational activities of oncology societies, among which ASCO and ESMO. He gave 4 oral presentations on clinical trials and 5 educational talks at the annual ASCO meetings. He is author or co-author of over 750 papers, of which more than 400 extended papers published in international indexed journals, and several books chapters. His papers have about 17.367 citations in international indexed journals. Dr. Gridelli has an h-index of 63.

In November 2013, the American agency Expertscape (Palo Alto, California) ranked Dr Gridelli at the first place among the top world experts in lung cancer.